𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Diabetes mellitus and risk of breast cancer: A meta-analysis

✍ Scribed by Susanna C. Larsson; Christos S. Mantzoros; Alicja Wolk


Publisher
John Wiley and Sons
Year
2007
Tongue
French
Weight
190 KB
Volume
121
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Diabetes mellitus has been associated with an increased risk of several types of cancers, but its relationship with breast cancer remains unclear. We conducted a meta‐analysis of case–control and cohort studies to assess the evidence regarding the association between diabetes and risk of breast cancer. Studies were identified by searching MEDLINE (1966–February 2007) and the references of retrieved articles. We identified 20 studies (5 case–control and 15 cohort studies) that reported relative risk (RR) estimates (odds ratio, rate ratio/hazard ratio, or standardized incidence ratio) with 95% confidence intervals (CIs) for the relation between diabetes (largely Type II diabetes) and breast cancer incidence. Summary RRs were calculated using a random‐effects model. Analysis of all 20 studies showed that women with (versus without) diabetes had a statistically significant 20% increased risk of breast cancer (RR, 1.20; 95% CI, 1.12–1.28). The summary estimates were similar for case–control studies (RR, 1.18; 95% CI, 1.05–1.32) and cohort studies (RR, 1.20; 95% CI, 1.11–1.30). Meta‐analysis of 5 cohort studies on diabetes and mortality from breast cancer yielded a summary RR of 1.24 (95% CI, 0.95–1.62) for women with (versus without) diabetes. Findings from this meta‐analysis indicate that diabetes is associated with an increased risk of breast cancer. © 2007 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Risk of endometrial and breast cancer in
✍ Elisabete Weiderpass; Gloria Gridley; Ingemar Persson; Olof Nyrén; Anders Ekbom; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 39 KB 👁 2 views

Diabetes mellitus patients have metabolic and endocrine alterations that could contribute to an increased incidence of hormone-related cancers. We assessed the incidence of endometrial and breast cancer among 80,005 women and the incidence of breast cancer among 73,847 men (total of 153,852 patients

Risk of adverse effects of intensified t
✍ Egger, M.; Davey Smith, G.; Stettler, C.; Diem, P. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

While the benefits of intensified insulin treatment in insulin-dependent (Type 1) diabetes mellitus (IDDM) are well recognized, the risks have not been comprehensively characterized. We examined the risk of severe hypoglycaemia, ketoacidosis, and death in a meta-analysis of randomized controlled tri

Diabetes mellitus and the risk of primar
✍ Carlo La Vecchia; Eva Negri; Adriano Decarli; Silvia Franceschi 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 39 KB 👁 2 views

The relationship between diabetes mellitus and primary liver cancer was investigated in a case-control study conducted in Italy between 1984 and 1996 on 428 cases with incident, histologically confirmed hepatocellular carcinoma, 59 with gallbladder and bile duct cancer, and 1,502 control subjects in

Family history and the risk of breast ca
✍ Paul D.P. Pharoah; Nicholas E. Day; Stephen Duffy; Douglas F. Easton; Bruce A.J. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 170 KB 👁 3 views

An increased risk of breast cancer in women with a family history of breast cancer has been demonstrated by many studies using a variety of study designs. However, the extent of this risk varies according to the nature of the family history (type of relative affected, age at which relative developed

IGF-I and breast cancer: A meta-analysis
✍ Runhua Shi; Herbert Yu; Jerry McLarty; Jonathan Glass 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 88 KB

## Abstract IGFs are peptide hormones involved in the regulation of cell proliferation, differentiation and apoptosis. IGFs are regulated by endocrine and paracrine mechanisms; however, their action in tissue is determined by circulating levels and local production of IGFs and IGF‐binding proteins